JAN 15, 2016 04:19 AM PST

New Blood Test Detects Melanoma's Spread

WRITTEN BY: Xuan Pham
Metastasis is one of the biggest challenges facing current available cancer treatments. It is this unpredictable progression of cancer that makes melanoma the most deadly form of skin cancers. But results from a new study may help doctors track the cancer’s spread by measuring levels of DNA from circulating tumor cells.
 
Circulating tumor DNA can help detect cancer's presence.

Circulating tumor DNA (ctDNA), also known as cell-free tumor DNA, is genetic material that’s freely floating in the bloodstream of cancer patients. The source of ctDNA is the tumor, where dead tumor cells break open and release the tumor DNA into the patient’s blood. ctDNA represents a non-invasive cancer biomarker that can indicate the presence of disease. And because detection requires only a blood sample, the technique of using ctDNA for cancer diagnosis is often called “liquid biopsy.”
 
The researchers proposed that ctDNA could provide an accurate way to track the progression of metastatic melanoma. Since the ctDNA is specific to the melanoma tumor, this new test could provide better diagnostic accuracy than traditional tests that measure an enzyme called lactate dehydrogenase (LDH). Though LDH levels do rise in presence of aggressive tumors, it is also affected by other health conditions, which could convolute the accuracy of the LDH screen.
 
In 31 patients who had advanced metastatic melanomas, researchers found that ctDNA levels were more predictive of the disease progression than levels of LDH. ctDNA levels were elevated in 80% of the patients, as compared to LDH levels that were elevated in only 30% of patients.
 
ctDNA levels were also better at predicting cancer recurrence (85% of patients) compared to LDH levels (54% of patients). Recurrence rates were confirmed by X-ray or CT scans.
 
Overall, the ctDNA screen had higher sensitivity than the LDH screen at detecting the spread of melanoma. 
 
"Our study results show that circulating tumor DNA is a superior blood test for evaluating and tracking progression of metastatic melanoma," said David Polsky, senior investigator from NYU Langone Medical Center in New York City.
 
While these results are promising, it is important to note that the study was done on a very small number of patients. It will be prudent for the scientists to expand on these preliminary results in a larger cohort of patients and controls. Larger trials should demonstrate with higher confidence the potential use of ctDNA as a biomarker for monitoring melanoma disease activity. 
 

Additional source: Medicine Net
About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
APR 24, 2018
Clinical & Molecular DX
APR 24, 2018
An Atlas of the Human Genome
Scientists from the Hebrew University of Jerusalem want to identify individual genes responsible for specific diseases. This goal inspired their new Nature...
MAY 07, 2018
Clinical & Molecular DX
MAY 07, 2018
Sensory Processing Important for Autism Diagnosis
At least than a year old, an individual’s response to light can predict whether or not they’ll be diagnosed with autism later in life. In a new...
MAY 22, 2018
Cancer
MAY 22, 2018
Novel PD-L1/TGF-ß Fusion Protein for HPV-Associated Cancers Enters Phase II Clinical Trial
Novel PD-L1/TGF-ß fusion protein for HPV-associated cancers enters phase II clinical trial. Oncology researchers excited about the potential of this bi-functional protein to combat cancer...
JUN 07, 2018
Clinical & Molecular DX
JUN 07, 2018
Digital Screening Vital for Detecting Breast Cancer
A combination of two digital techniques could be the best way to diagnose breast cancer. In a new study, scientists show how combining a technique called t...
JUL 01, 2018
Videos
JUL 01, 2018
Growing Patient Cells on a Chip for Personalized Drug Screens
This work could help eliminate animal models, and tailor medicine to the patient....
JUL 19, 2018
Microbiology
JUL 19, 2018
Mom's Microbiome has a Big Impact on Kid's Autism Risk
For many years, scientists have been trying to learn more about the causes of autism....
Loading Comments...